Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1/2 1Phase 1 1

Status

Completed 22Unknown 5Recruiting 4Not yet recruiting 4Active not recruiting 4Withdrawn 3Terminated 3

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Mouth Neoplasms 4Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 1Sentinel Lymph Node Biopsy (SLNB) 1Recurrence 1Penile Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Melanoma 1Lymphatic Metastasis 1Endometrial Neoplasms 1Eccrine Porocarcinoma 1Carcinoma, Squamous Cell 1Carcinoma, Merkel Cell 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

Fulvestrant 58Trastuzumab 49Capecitabine 48Letrozole 45pembrolizumab 41Carboplatin 41Paclitaxel 39Cyclophosphamide 38ribociclib 37pertuzumab 36abemaciclib 36Blood Specimen Collection 31Specimen Handling 28trastuzumab deruxtecan 27Docetaxel 27Surveys and Questionnaires 26Anastrozole 25exemestane 24Tamoxifen 24palbociclib 21130-nm albumin-bound paclitaxel 21Magnetic Resonance Spectroscopy 20Biopsy 19sacituzumab govitecan 18eribulin 18Radiotherapy 18Gemcitabine 18olaparib 17Injections 17Epirubicin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Breast Neoplasms × Sentinel Lymph Node Biopsy × Clear all
NCT07579286 2026-05-12

LumiNOde

N.N. Petrov National Medical Research Center of Oncology

Phase NA Recruiting
100 enrolled
Breast

Breast Neoplasms

NCT07146295 2026-01-12

INFINITE

St. Antonius Hospital

Phase NA Recruiting
1,760 enrolled
Breast

Breast Neoplasms, Lymphatic Metastasis

NCT06121570 2023-11-08

Phase I Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 1 Recruiting
24 enrolled
Breast

Breast Neoplasms

NCT05981014 2023-08-08

Study of Autologous Tumor-Draining Lymph Node-Derived Lymphocytes as Neoadjuvant Therapy for HER2-Negative Breast Cancer

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 1/2 Recruiting
196 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡